(Q44897536)

7 December 2017

Mental healthcare staff's knowledge and experiences of diabetes care for persons with psychosis--a qualitative interview study (English)

1 reference

7 December 2017

1 reference

Sally Hultsjö

1

1 reference

PubMed ID

22784379

7 December 2017

language of work or name

1 reference

12 July 2012

1 reference

Primary Health Care Research and Development

7 December 2017

1 reference

7 December 2017

14

1 reference

7 December 2017

3

1 reference

7 December 2017

281-292

1 reference

A comparison of type 2 diabetes outcomes among persons with and without severe mental illnesses

7 December 2017

1 reference

https://api.crossref.org/works/10.1017%2FS1463423612000321

Comorbidity of medical illnesses among adults with serious mental illness who are receiving community psychiatric services.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1463423612000321

Quality of life in individuals with serious mental illness and type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1463423612000321

Diabetes, common mental disorders, and disability: findings from the UK National Psychiatric Morbidity Survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1463423612000321

Increasing lifestyle physical activity in patients with depression or other serious mental illness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1463423612000321

Care provided by general practitioners to patients with psychotic disorders: a cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1463423612000321

Monitoring patients to improve physical health and treatment outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1463423612000321

Effectiveness of weight management interventions for people with serious mental illness who receive treatment with atypical antipsychotic medications. A literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1463423612000321

Treatment with antipsychotics and the risk of diabetes in clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1463423612000321

Care and management of cardiovascular risk factors among individuals with schizophrenia and type 2 diabetes who smoke

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1463423612000321

Influence of a lifestyle intervention among persons with a psychiatric disability: a cluster randomised controlled trail on symptoms, quality of life and sense of coherence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1463423612000321

Evolving self-care in individuals with schizophrenia and diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1463423612000321

Nursing care of clients treated with atypical antipsychotics who have a risk of developing metabolic instability and/or type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1463423612000321

Are there specific care requirements for patients with schizophrenia and diabetes or with a risk of diabetes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1463423612000321

Effects of behavioral therapy on weight loss in overweight and obese patients with schizophrenia or schizoaffective disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1463423612000321

inferred from DOI database lookup

7 January 2021

based on heuristic

Elevated hemoglobin A1c as a possible indicator of diabetes mellitus and diabetic ketoacidosis in schizophrenia patients receiving atypical antipsychotics.

1 reference

https://api.crossref.org/works/10.1017%2FS1463423612000321

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1017/S1463423612000321

1 reference

7 December 2017

1 reference

PubMed ID

22784379